Triple helix forming oligonucleotides can direct DNA damaging agents at specific sites in an intact double helix. In our study, triple helix formation was demonstrated in a SV40 based shuttle vector treated with psoralen linked to a 22-mer purine rich oligonucleotide. UVA irradiation caused a covalent linkage of the oligonucleotide through the psoralen to the mutational supF marker gene of the plasmid. After passage in the Jurkat human cell line the recovered vector was analysed in an indicator bacterial strain and mutants were collected. The presence of adducts in the target sequence did not reduce the yield of replicated progeny vector molecules, indicating repair of triple helix associated monoadducts and cross-links. Mutations were highly targeted to a six nucleotide long region of the target sequence. The number of target sequence mutants obtained after triple helix directed psoralen treatment was approximately 160 times higher than with free psoralen. A further investigation of the exact mechanism of the mutational process could make triple helix directed mutagenesis a more useful tool in gene therapy, antiviral therapy, and in studies on DNA repair and genome organisation.
INTRODUCTION
It is well known that oligonucleotides can bind to the major groove of homopurine/homopyrimidine stretches of double stranded DNA and form triple helices. Homopyrimidine oligonucleotides bind in parallel orientation while homopurine oligonucleotide bind in antiparallel orientation compared to the purine rich strand of the double helix (1 -3) . Binding is sequencespecific and in the case of purine rich oligonucleotides it is stabilised in vivo mainly by hydrogen bonds in G.GC triplets (4) . Once a triple helix forming oligonucleotide is attached to the target sequence it inhibits the activity of DNA binding proteins like restriction endonucleases, methylases, transcription factors and RNA polymerases (for review see ref. 3, 5) . Therefore, triple helix forming oligonucleotides have a great potential as artificial gene repressors in antigene strategies.
By coupling of the oligonucleotide to various DNA damaging agents, a covalent modification of the triple helix sequence can be achieved. Thus, crosslinking of the two strands of the DNA by psoralen (6) (7) (8) and chlorambucil (9) , and DNA cleavage by ellipticine (10) , phenanthroline-Cu chelate (11) , and EDTA-FeflT) (12) have been reported. Despite the great knowledge of triple helix formation in vitro little is known about the repair and mutagenic effects of these covalent modifications in vivo.
In order to obtain a better understanding of the potential of triple helix forming oligonucleotides as site specific mutagens, we have examined the repair and mutagenesis of triple helix targeted psoralen monoadducts and crosslinks in human cells. Triple helix was formed between a shuttle vector supF mutational marker gene and an oligonucleotide linked to psoralen. Exposure to 365 nm UV light gave rise to both monoadducts and interstrand crosslinks. Human lymphoblastoid cells transfected with this DNA were able to repair both of these two types of lesion, however, the crosslinks were mutagenic. Sequence analysis showed that the mutations were highly targeted to the site of the psoralen damage. All mutants bore a single point mutation, contrasting to a recent report on triple helix mediated vector mutagenesis in monkey cells where small deletions were also reported (13) .
MATERIALS AND METHODS

Plasmid and oligonucleotide
pSPTx ( Figure 1 ) is a derivate of the SV40 based shuttle vector pSP189 (14) . The plasmid contains the early transcription unit of SV40 which allows replication in human cells. The mutational target amber suppressor tRNA gene supF is placed between the bacterial replication origin and the beta-lactamase gene. Mutations in this region can easily be detected in a lacZ amber mutant E.coli indicator strain (15) . After the transcription terminator comes an 8 bp long random 'signature' sequence permitting the identification of different clones carrying the same mutation (14) . During the construction of pSPTx the Eagl-BamHl fragment of pSP189 was replaced by a polylinker creating a 22 bp purine rich stretch and a unique Smal site immediately after the tRNA gene.
The 22-mer triple helix forming psoralen modified oligonucleotide (TFO1) was obtained from Appligene (ILLKIRCH Cedex, France). The psoralen molecule is linked via its C5 position to the 5Vi end of the oligo through a *To whom correspondence should be addressed hexamethylene linker (Figure 1 ). The 20-mer sequencing primer (pS) binding upstream of supF gene was obtained from Scandinavian Gene Synthesis AB (Koping, Sweden).
Triple helix and psoralen adduct formation
For triple helix formation 5 ng pSPTx was incubated in the presence of 100 molar excess of TFO1 (5 jtM concentration) in 30 ill 10 mM Tris-HCl pH 7.4, 20 mM MgCl 2 buffer at 37°C for 1 h (unless other data are indicated). For covalent psoralen adduct formation the samples were kept in a microtiter plate on ice and irradiated with 0.8 mW/cm 2 UVA of a hand held long wave UV lamp (Model UVL-56, Ultra-Violet Products, Inc.). Photoreversion was carried out by irradiation with 0.15 mW/cm 2 UVC light of an ordinary germicidal lamp for 15 min. Free psoralen control experiments were performed under the same conditions, using 1.08 jtg/ml of 8-methoxypsoralen (8-MOP) (1:100 plasmid:8-MOP molar ratio).
All restriction endonuclease digestions and the 3' labeling by Klenow polymerase and S 35 -adATP were carried out according to standard protocols (16) . Radioactivity corresponding to autoradiogram bands was determined using scanning densitometry and also in gel slices by an LKB-Wallac 1209 liquid scintillation counter.
In die primer extension assay the template was denatured, pS primer annealed and samples incubated with 1U Klenow polymerase in the presence of 0.15 /*M dCTP, dGTP, dTTP, respectively, and 0.5 /*M S 35 -adATP in 13.5 /d 30 mM Tris-HCl pH 7.5, 15 mM MgCl 2 , 37 mM NaCl buffer at room temperature for 10 min. Then the nucleotide concentration was raised by adding 10 pi 180 /tM dNTP, 50 mM NaCl solution and further incubated at room temperature for 10 min. The reaction was stopped with 16 /d 95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF. 2 ml of the samples were electrophorised in a 6% polyacrylamide sequencing gel.
Cell transfection
The human lymphoblastoid T cell line Jurkat was maintained in RPMI 1640 medium supplemented with 15% fetal calf serum, L-glutamine and gentamicin. In transfection experiments 1-2xlO 7 cells were washed and suspended in 0.5 ml RPMI. TFO1 treated pSPTx in 30 /tl of triple helix forming buffer was added and the cells were kept on ice for 5 min. After electroporation (0.45 kVolt, 400 Ohm, 960 /iFarad) (Gene Pulser, Biorad) the cells were suspended in 20 ml complete medium.
Mutant analysis
Two days after the cell transfection low molecular weight DNA was isolated from the cell cultures with Qiagen plasmid kit (Qiagen GmbH). Unreplicated plasmids were eliminated by Dpnl digestion and the DNA was transformed into the MBM7070 E. coli indicator strain by electroporation. This strain carries an amber mutation in the chromosomal lacZ gene and forms white colonies on plates containing X-gal and IPTG. In bacteria carrying plasmid pSPTx the suppressor tRNA coded by the supF gene suppresses the mutation and the bacteria form blue colonies. White or lightblue colour of colonies growing on an ampicillin-enriched agar plate indicates the presence of a plasmid bearing a mutated supF gene. Mutant plasmid DNA was isolated with Qiaprep-spin plasmid kit (Qiagen GmBH) and sequencing was carried out with Sequenase Kit (USB) according to the manufactural protocol.
RESULTS
Design of triple helix forming oligonucleotide
Triple helix formation between a homopurine oligonucleotide and a 10 bp long homopurine stretch of the supF gene has been reported (13, 17) . At the end of the supF tRNA gene of our pSPTx vector there is a 22 bp long purine rich sequence containing 16 guanines, 3 adenines and 3 thy mines. Purine rich triple helix forming oligonucleotides bind into the major groove of the target sequence antiparallel to the purine rich strand via hydrogen bonds mainly between GC.G triplets and to a less extent between AT.A or AT.T triplets. None of the four nucleotides can specifically bind to TA base pairs in a purine rich triple helix (1, 2) . We decided to use a 22-mer oligonucleotide named TFO1, exactly the same sequence as the purine rich strand of the pSPTx target region but in opposite orientation, which can form triple helix through 16 GC.G, 3 AT.A and 3 TA.T triplets. A psoralen group is coupled to the 5' end of the oligonucleotide at its C5 position via a hexamethylene linker and has the potential to react (upon UVA irradiation) with two thymine residues and thus form a crosslink between the two strands of the target DNA. The psoralen moiety will be positioned around the 167 nucleotide pair of the tRNA gene since purine rich triple helix forming oligonucleotides bind to DNA in parallel orientation compared to the pyrimidine strand ( Figure 1 ). At the 166-168 location there are two thymine residues in the purine rich strand and one in the pyrimidine rich strand of the target sequence which all might react with the psoralen to covalently bind TFO1 to the strands of the plasmid. Although previous shuttle vector experiments have failed to detect 8-MOP photoproducts at this position (18) , with triple helix directed psoralen both monoadducts and interstrand crosslinks has been observed (13) .
Detection of triple helix formation in pSPTx by inhibition of restriction endonuclease cleavage
The blocking of restriction endonuclease cleavage is a convenient method for the detection of triple helix formation in supercoiled plasmid DNA (19) . In shutde vector pSPTx the triple helix forming target site is overlapping by three base pairs the recognition sequence of Smal ( Figure 1 ).
Increasing amounts of TFO1 was incubated with 100 fmole (~ 330 ng) 50% supercoiled pSPTx in 10 ^1 triple helix forming buffer for 1 h at 37°C. UV radiation was not applied in this experiment. The plasmid was then digested with Smal, ethanol precipitated and finally incubated with Stul. With a triple helix containing plasmid this latter enzyme is expected to linearise the vector, whereas a triplex free vector should become cut also by Smal giving two fragments (3.5 and 1.5 kb). The samples were run on a 1 % agarose minigel and stained with ethidium bromide (Figure 2) .
As expected the triple helix 5.0 kb vector can be easily distinguished from the 3.5 kb and 1.5 kb fragments of the triple helix free plasmid. Although the inhibition by TFO1 of the Smal cleavage is detectable already at a 1:1 plasmid: TFO1 molar ratio (0.01 jtM TFO1 concentration), it is still not complete even at 1:1000 plasmid:TFO1 molar ratio (10 /iM TFO1 concentration). One explanation can be that the oligonucleotide is not covalently linked to the target sequence and the enzyme has the possibility to displace it. A non triple helix forming oligonucleotide (even in 1000 molar excess) can not inhibit Smal cleavage. Furthermore, at a high concentration of TFO1 the Sma I digestion of a plasmid lacking the triple helix target site is not influenced. From these experiments we conclude that the inhibition of Sma I cleavage is due to the sequence specific triple helix formation between TFO1 and the target sequence of plasmid pSPTx. We can also presume that at the 1:100 plasmid:TFO molar ratio used in the further experiments triple helix was formed in more than half of the vector molecules.
UV light mediated covalent triple helix formation pSPTx plasmid was incubated with a 100 molar excess of TFO1 in triplex forming buffer, UVA irradiated for different times, ethanol precipitated and digested with Xhol. The purine rich strand of the target was then 3' end labeled with Klenow polymerase and the supF gene fragment released from the rest of the plasmid by BamH I digestion. In order to label instead the pyrimidine rich strand the plasmid was first cut with BamH I, labeled with Klenow polymerase and finally digested with Xho I. Samples were run on a denaturing polyacrylamide gel and the radioactivity of each band was determined.
As expected, samples without UVA radiation migrated as two bands (Figure 3) . The lower band corresponds to the labelled purine rich strand of the supF gene fragment. The upper band is the rest of the plasmid. A low UVA dose (30 sec) leads to the appearance of an additional third band. This band can be presumed to correspond to monoadducts on the purine rich strand. According to radioactivity measurements following 2 min irradiation 50% of the supF gene fragments had reacted with psoralen. After 8 min irradiation also a fourth more slowly migrating upper band appears, presumably representing crosslinks linking together both strands of the target sequence. As determined by scanning densitometry, a small fraction of the radioactivity (~2%) was located at the expected position of this band already at the 2 min UVA dose. The cross-link nature of this fragment is further supported by UVC photoreversion of psoralen crosslinks (20) which eliminated this fourth band ( Figure  3, lane 9 ). In the sample irradiated for 32 min 25% of the fragments contained a crosslink, 60% a monoadduct and 15% of the purine rich strand were unmodified (lane 8).
To get some information about the position of the crosslink in the supF coding region a mutant plasmid was employed bearing adenine instead of thymine at position 167 precluding interstrand crosslink formation. This mutation was found to completely eliminate the crosslink band, (Figure 3 the only crosslink formed in the tRNA coding region is between the two opposing thymines at positions 166 and 167. If instead the pyrimidine rich strand is labelled, only weak monoadduct formation is seen after 2 min irradiation (data not shown) and this low level (10%) seems to remain even after 32 min of UVA (Figure 3, lane 11. ). These data suggest that most of the psoralen react first with the purine rich strand of the target sequence. Upon further irradiation some of the monoadducts will react to form interstrand crosslinks. It is known that only the furan side monoadducts can be converted to a crosslink (21) proposing that the orientation of most of the crosslinks is such that the furan side of the psoralen is linked to the guanine rich strand.
Primer extension assay
A DNA polymerase is expected to stop its synthesis when a bulky adduct like psoralen plus oligonucleotide is encountered. Therefore, in order to localise the precise position of psoralen adduct formation on the purine rich strand of the supF gene, we performed DNA polymerisation from a primer attached upstream of the tRNA gene. The Klenow fragment of DNA polymerase I was used which stops one nucleotide proximal to the damaged site (22) . pSPTx was treated with 100 molar excess of TFO1, irradiated with UVA, incubated with Klenow polymerase and run on a denaturing polyacrylamide gel as detailed in Materials and Methods.
With increasing UVA dose a band appears which migrates as the position 165 A band of the sequencing ladder (Figure 4 ). This stop position demonstrates the presence of a psoralen adduct at position 166. The very faint band appearing just under the strong band probably is due to monoadduct formation at position 165. We can also conclude that there is no other reaction site on the purine rich strand of the tRNA gene. These results give evidence of strongly targeted monoadduct formation. The primer extension assay probably can not detect crosslinks since this type of lesion prevents complete denaturation of the template and thus may inhibit primer annealing and polymerisation.
Analysis of shuttle vector recovered from cell transfections
Shuttle vector pSPTx was incubated in the presence of a 100 molar excess of TFO1 and treated with long wave length UV. We used untreated , UVA treated and 8-MOP+UVA treated vector as controls. Jurkat cells were transfected with the plasmid and two days later low molecular weight DNA was prepared. Unreplicated plasmids were eliminated by Dpnl digestion and the DNA was transformed into the E.coli indicator strain. The numbers of colonies and mutants were determined and from these data plasmid survival and mutation frequency were calculated. The results are presented in Table I .
The background mutation frequency was 0.06%, and was unaffected by treatment with TFO1. As the result of treatment with TFO1 plus UV radiation the mutation frequency increased as more and more UVA light was applied. At die highest UVA dose the mutation frequency is 1.3%, i.e. 16 times higher than obtained by free psoralen treatment (0.08%). The survival of plasmid was decreased to about 10% as the result of 8-MOP treatment, while it was practically unchanged in the TFO1 treated samples.
The sequencing analysis of mutants from the triple helix treated plasmid transfection was greatly facilitated by the presence of the signature sequence. Since all of the sequenced mutants showed different signature sequences, they could be counted as independent mutations. In the free psoralen treated sample sequencing of 20 mutants showed five deletions, one multiple point mutation and fourteen single point mutations. When TFO1 was used only single point mutants were found among the 20 mutants sequenced. The exact positions of the point mutants are presented in Figure 5 . In the triple helix treated sample 90% of the mutations were found in a six base pair long region of the supF gene from position 163 to 168. 65% of the mutations were at position 167 where T to A and T to G transversions and a one base pair deletion were detected. In the case of 8-MOP treatment the mutations were evenly distributed along the whole coding region of the tRNA gene. One weak hot spot at position 137 was seen, being the only site where psoralen adduct formation has been observed previously.
DISCUSSION
Triple helix formation was used to direct a psoralen molecule to a specific site in an SV40 shuttle vector. We could observe formation of both monoadducts and crosslinks at the expected position of the supF mutational marker gene. After 2 min of UVA irradiation about 60% of the plasmids were found to contain monoadducts (at position 165-167), while only 2% had interstrand crosslinks. With increasing UVA dose interstrand crosslink formation was observed between the thymine residues at positions 166 and 167. At 32 min irradiation 25% of the target sequence molecules are crosslinked, 60% have a monoadduct on the purine rich strand, 10% have a monoadduct on the pyrimidine rich strand and 5% of them are free from any modification. Preliminary data of a previous work on triple helix directed psoralen in the supF gene snowed that 63 % of the vector molecules had crosslinks, 22% monoadducts at position 166 and 9% monoadducts at position 167 (13) . The most likely cause of these variations in result is the different structure of the psoralen oligonucleotide conjugates. In our TFO1 psoralen is attached to a six carbon linker via its C5 position and the oligonucleotide is 22 bases long while in the other case 4'-hydroxymethyl-4,5',8-trimethylpsoralen is linked to a 10-mer through a two carbon linker. Therefore, it is reasonable to anticipate different psoralen intercalation and photoproduct yield.
To examine the repair and mutagenicity of triple helix mediated psoralen adducts the shuttle vector was transfected into Jurkat cells. Treatment with free psoralen caused a strong reduction of plasmid survival but only a modest increase in mutation frequency. In sharp contrast, triple helix directed adducts did not affect the survival but clearly raised the mutation frequency. Two properties of the supF triple helix region, contrasting to those of the surrounding vital regions of the vector, contribute to these striking differences: (i) a relatively weak induction of psoralen adducts (18) and (ii) a high tolerance of point mutations. Thus, the survival and mutation results give further proof that the damage caused by TFO1 is indeed strongly targeted to the area of supF gene, but evenly distributed in the whole vector in the case of free psoralen. Furthermore, from the mutation frequency and plasmid survival data we can conclude that the absolute number of mutants that can be obtained from one cell transfection is approximately 160 (i.e. 1.3%/0.08% multiplied by 10) times higher in the TFO1 treated sample than in the 8-MOP treated one.
At the 2 min UVA dose the normal plasmid survival and low mutation induction indicate that monoadducts are efficiently repaired. As more UVA radiation was applied the mutation frequency clearly increased suggesting an error-prone cellular processing of crosslinks. These findings are in agreement with the previous observations of psoralen adduct repair where the interstrand crosslink was found to be a highly mutagenic lesion (23, 24) . On the other hand, the 1.3% mutation frequency value proposes that only a minority of the 25 % of the molecules shown to contain a crosslink became mutated. This observation is in good agreement with data of others where a 7.3% mutation frequency was detected as a result of a 63 % crosslinked target sequence (13) . It could be that most of the crosslinked vectors are eliminated perhaps as a result of repair attempts causing large deletions, however, the normal plasmid survival argues against this hypothesis. Some more Likely explanations can be formulated on the basis of the present knowledge regarding mechanisms of DNA cross-link repair, as outlined below.
In current psoralen crosslink repair models (25, 26) one strand of the DNA is incised on both sides of the crosslink, the gap is filled by translesion synthesis by an error prone polymerase, the psoralen is excised from the other strand and this second gap is also filled by a DNA polymerase. In our experiments mutations were highly targeted at a six base pair region of the supF gene, 65% of them at position 167. Havre and Glazer observed that all point mutation were in a four base pair region 79% of them at position 167 (13) . These results suggest that first the purine rich strand is cut around the psoralen adduct and the gap becomes filled while the structure composed of psoralen, oligonucleotide and part of the purine rich strand remains attached to the 167 thymine residue of the pyrimidine rich strand of the target. In this model the induction of mutations depends on the accuracy of the gap filling. If the polymerase property to preferentially insert an adenine opposite the damaged site (27, 28) applies then the damage would be repaired correctly. Insertion of a thymine or a cytosine nucleotide causes T to A and T to G transversions, respectively, which we could observe at approximately the same ratio in contrast to a previous work where only T to A mutations were reported at this position (13) . T to C mutation at position 167 so far has not been reported, probably because it does not inactivate the tRNA gene (15) . The relatively low mutation frequency, as compared with the adduct frequency, also can be explained by an error free repair pathway of psoralen crosslinks involving recombination. This pathway using a second homologous DNA strand has been reported in bacteria (25, 26, 29, 30 ) and a similar pathway might exist in mammalian cells (31) . Whether triple helix directed psoralen crosslinks are repaired mainly by error prone or error free pathways needs to be further investigated.
In contrast to our work where only point mutations were detected others also reported small deletions around the triple helix damaged site (13) . Deletion formation indicates that the normal repair of the psoralen adduct is seriously disturbed. In this case it may be that repair incision on one side of the psoralen adduct is inhibited by the triple helix, activating a more error prone repair process, thus creating deletions.
From the aspects of gene and antigene therapy the next conclusions can be drawn. Triple helix forming oligonucleotide coupled with psoralen can interfere with die normal functions of DNA at two levels. Firstly, a temporary inhibition of the binding of proteins to DNA and of gene expression can be achieved (3, 5) . For this purpose psoralen adduct formation could be detrimental since our data suggests that psoralen damage might serve as a signal for the active removal of the whole triplex structure, while a simple triple helix might persist as a quasi normal structure for a longer time.
Secondly, permanent alteration of DNA function at the level of the coded information, by means of triple helix mediated psoralen crosslink mutagenesis, can be achieved. Unfortunately, some limitations to this triple helix targeted mutagenesis has been seen; e.g. mutations can be introduced only at close proximity of the triple helix forming region, mutations seem to engage not only a single position, and the type of the mutation can not be predicted. Perhaps a more precise alteration of the genetic information can be reached by use of repair-coupled homologous recombination. Therefore, a better understanding of how psoralen crosslink damage is processed by human cells might lead to the control not only of the site of the mutation but also of the exact type of it.
